NCT04703855View on ClinicalTrials.gov

Hong Kong and Taiwan HM3 PMS

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

June 30, 2022

Conditions
Advanced Heart Failure
Interventions
DEVICE

HeartMate 3™ left ventricular assist system (HM3 LVAS)

Advanced heart failure patients will be implanted with the HM3 LVAS

Trial Locations (3)

100

National Taiwan University Hospital, Taipei

114

Tri-Service General Hospital, Taipei

Unknown

University of Hong Kong, Hong Kong

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT04703855 - Hong Kong and Taiwan HM3 PMS | Biotech Hunter | Biotech Hunter